CAH
Price
$213.46
Change
-$0.10 (-0.05%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
50.74B
21 days until earnings call
Intraday BUY SELL Signals
HSIC
Price
$78.09
Change
+$1.83 (+2.40%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
8.98B
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CAH vs HSIC

Header iconCAH vs HSIC Comparison
Open Charts CAH vs HSICBanner chart's image
Cardinal Health
Price$213.46
Change-$0.10 (-0.05%)
Volume$12.65K
Capitalization50.74B
Henry Schein
Price$78.09
Change+$1.83 (+2.40%)
Volume$48.92K
Capitalization8.98B
CAH vs HSIC Comparison Chart in %
CAH
Daily Signal:
Gain/Loss:
HSIC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CAH vs. HSIC commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a Hold and HSIC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (CAH: $213.56 vs. HSIC: $76.26)
Brand notoriety: CAH and HSIC are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 77% vs. HSIC: 120%
Market capitalization -- CAH: $50.74B vs. HSIC: $8.98B
CAH [@Medical Distributors] is valued at $50.74B. HSIC’s [@Medical Distributors] market capitalization is $8.98B. The market cap for tickers in the [@Medical Distributors] industry ranges from $102.96B to $0. The average market capitalization across the [@Medical Distributors] industry is $12.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 3 FA rating(s) are green whileHSIC’s FA Score has 0 green FA rating(s).

  • CAH’s FA Score: 3 green, 2 red.
  • HSIC’s FA Score: 0 green, 5 red.
According to our system of comparison, CAH is a better buy in the long-term than HSIC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 5 TA indicator(s) are bullish while HSIC’s TA Score has 3 bullish TA indicator(s).

  • CAH’s TA Score: 5 bullish, 4 bearish.
  • HSIC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CAH is a better buy in the short-term than HSIC.

Price Growth

CAH (@Medical Distributors) experienced а +3.07% price change this week, while HSIC (@Medical Distributors) price change was -2.41% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +6.74%. For the same industry, the average monthly price growth was +12.51%, and the average quarterly price growth was +28.73%.

Reported Earning Dates

CAH is expected to report earnings on Feb 05, 2026.

HSIC is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Medical Distributors (+6.74% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAH($50.7B) has a higher market cap than HSIC($8.98B). CAH has higher P/E ratio than HSIC: CAH (32.21) vs HSIC (24.06). CAH YTD gains are higher at: 4.181 vs. HSIC (0.900). CAH has higher annual earnings (EBITDA): 3.26B vs. HSIC (948M). HSIC has less debt than CAH: HSIC (3.44B) vs CAH (9.03B). CAH has higher revenues than HSIC: CAH (234B) vs HSIC (12.9B).
CAHHSICCAH / HSIC
Capitalization50.7B8.98B565%
EBITDA3.26B948M344%
Gain YTD4.1810.900465%
P/E Ratio32.2124.06134%
Revenue234B12.9B1,814%
Total CashN/A136M-
Total Debt9.03B3.44B262%
FUNDAMENTALS RATINGS
CAH vs HSIC: Fundamental Ratings
CAH
HSIC
OUTLOOK RATING
1..100
8077
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
282
SMR RATING
1..100
9965
PRICE GROWTH RATING
1..100
649
P/E GROWTH RATING
1..100
2175
SEASONALITY SCORE
1..100
6575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HSIC's Valuation (75) in the Medical Distributors industry is in the same range as CAH (86). This means that HSIC’s stock grew similarly to CAH’s over the last 12 months.

CAH's Profit vs Risk Rating (2) in the Medical Distributors industry is significantly better than the same rating for HSIC (82). This means that CAH’s stock grew significantly faster than HSIC’s over the last 12 months.

HSIC's SMR Rating (65) in the Medical Distributors industry is somewhat better than the same rating for CAH (99). This means that HSIC’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Price Growth Rating (6) in the Medical Distributors industry is somewhat better than the same rating for HSIC (49). This means that CAH’s stock grew somewhat faster than HSIC’s over the last 12 months.

CAH's P/E Growth Rating (21) in the Medical Distributors industry is somewhat better than the same rating for HSIC (75). This means that CAH’s stock grew somewhat faster than HSIC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHHSIC
RSI
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
46%
Advances
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 11 days ago
50%
Declines
ODDS (%)
Bearish Trend 7 days ago
43%
Bearish Trend 3 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signal:
Gain/Loss:
HSIC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGDIX15.370.10
+0.65%
TCW Relative Value Large Cap I
IMCVX9.450.06
+0.64%
Voya Multi-Manager Mid Cap Value I
EKWAX160.561.00
+0.63%
Allspring Precious Metals A
HKDCHF0.10N/A
N/A
Hong Kong Dollar - Switzerland Franc
RUBCHF0.01N/A
N/A
Russia Ruble - Switzerland Franc

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with MCK. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
+2.54%
MCK - CAH
55%
Loosely correlated
+1.24%
COR - CAH
52%
Loosely correlated
+1.17%
HSIC - CAH
18%
Poorly correlated
+0.58%
YI - CAH
17%
Poorly correlated
+15.20%
SHTDF - CAH
12%
Poorly correlated
N/A
More

HSIC and

Correlation & Price change

A.I.dvisor tells us that HSIC and MCK have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and MCK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
+0.58%
MCK - HSIC
17%
Poorly correlated
+1.24%
QIPT - HSIC
16%
Poorly correlated
+0.56%
SHTDY - HSIC
11%
Poorly correlated
-0.48%
AHG - HSIC
11%
Poorly correlated
-2.41%
CAH - HSIC
9%
Poorly correlated
+2.54%
More